RF Acquisition Corp II Prices $100M IPO; Research Alliance Announces Pediatrics Merger
RF Acquisition Corp II (RFAI) priced a $100M IPO backed by Alfa 24 Limited, while Research Alliance Corp III (RACC) announced plans to combine with OHB Pediatrics Ltd pending shareholder approval and regulatory clearance.
IPO Pricings
RF Acquisition Corp II (RFAI), sponsored by Alfa 24 Limited, priced its initial public offering at $100 million. The blank-check vehicle has completed its capital raise and is now entering the acquisition-search phase. Alfa 24's committed sponsor capital, deployed alongside public shareholder funds, positions RFAI to identify and evaluate potential business combination targets aligned with the sponsor's stated investment strategy and sector focus.
Deal Announcements
Research Alliance Corp III (RACC) announced plans to combine with OHB Pediatrics Ltd. The transaction brings a pediatrics-focused operating company into the public markets through a SPAC merger structure. The deal is subject to approval by RACC shareholders and satisfaction of customary closing conditions, including regulatory clearance and exchange listing compliance. RACC shareholders must vote to approve the proposed combination, and the merged entity cannot commence public operations until all requisite regulatory and listing requirements are satisfied. Standard SEC filings and corporate updates are expected as the transaction progresses toward shareholder vote and final regulatory approval prior to closing.